Searched for
CLL
Hulk Hogan cause of death: Police close investigation nearly one year after wrestling legend's passingClearwater Police have officially closed their investigation into the July 2025 death of wrestling legend Hulk Hogan, whose real name was T...- Hulk Hogan’s death sparks mystery - Was it malpractice? Has he already been cremated?Wrestling legend Hulk Hogan, 71, passed away on July 24, 2025, leaving fans and family shocked. While authorities cited it as a heart attac...
- What is Chronic Lymphocytic Leukemia? See details about the cancer that affected Hulk Hogan before his deathWhat is Chronic Lymphocytic Leukemia? This cancer affected Hulk Hogan before his death. Hogan’s death revealed he had chronic lymphocytic l...
- Hulk Hogan’s cause of death revealed — he was secretly fighting a second, deadlier illnessHulk Hogan’s cause of death has been revealed. He died at 71 from a heart attack at his Florida home. Medical reports confirmed he also had...
- Zydus Lifesciences gets tentative nod from USFDA for generic blood cancer drugZydus Lifesciences received tentative USFDA approval for its generic Ibrutinib tablets, used to treat various blood cancers like CLL/SLL an...
- New Zealand Budget 2025 deals a big blow to blood cancer patientsThe New Zealand government's 2025 Budget does not include new funds for blood cancer medicines. This decision disappoints patients and advo...
- CapitaLand India Trust to acquire 2.5 million sq ft of IT buildings at HITEC City, HyderabadCapitaLand India Trust (CLINT) has partnered with Phoenix Group to acquire two IT buildings in HITEC City, Hyderabad, with a total leasable...
- FDA gives second approval to Eli Lilly's drug for type of blood cancerEli Lilly said the health regulator gave the new approval to the drug for the treatment of chronic lymphocytic leukemia (CLL), a type of ca...
- WKYC Channel 3 news anchor, Jim Donovan, faces Leukemia diagnosis once againJim Donovan informed about his leukamia relapse during an episode of 3 News' Front Row. He had earlier been diagnosed with chronic lymphocy...
- RIL brings back chatbot to assist investors on rights issueIn a regulatory notice, Reliance said it had issued and allotted 42.26 crore partly paid-up equity shares of a face value of Rs 10 each for...
- Centre announces scheme for Northeast India industrialisationGovernment will provide necessary allocations for remaining period of scheme after assessment before March 2020.
- UK scientists find new cancer-killing techniqueScientists in the UK have found a new way to combat cancer by getting tumour cells addicted to drugs that will kill them in minutes. BH3-mi...
- Thirteen stocks in focus in Tuesday's tradeIndian markets are expected to trade in a range. Here is a list of thirteen stocks which are likely to remain in focus today.
- Claris Life surges over 10% on buzz of injectable business saleStocks of Claris Lifesciences surged over 10% today amid reports that Cadila Healthcare has emerged as the front runner to acquire the gene...
- Claris Lifesciences ends 10% up on reports of sale of injectable biz for Rs 3400 croreClaris Lifesciences ended the day at Rs 310.30; up 10.43%, after surging as much as 17.79 per cent in intraday trade.
- Sensex cuts losses, Nifty back past 8400; Claris zooms 17%, Tata Steel shrinks 6%The S&P BSE Sensex started on a cautious note in trade on Thursday following muted trend seen in other Asian markets.
- Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 croreBoth sides are currently engaged in last-minute due diligence negotiations involving tax and other financial matters, said at least five so...
- Big pharma eyes takeover of Claris’ injectables business for Rs 2500-Rs 3000 croreCarlyle private equity backed CLL has transferred its speciality injectables business into a wholly owned subsidiary called CIL.
- Holy Mess“The breath of life is what finally kills you,” ends Status Quo Vadis, the poem ex-pat Australian poet Clive James wrote six years ago. The...
- Subscribe to Claris Lifesciences IPO: KR ChokseyKR Choksey has recommended investors to ‘Subscribe’ to the initial public offering of Claris Lifesciences.
Load More
